LRRK2 and Parkinson disease: In a study of 106 patients, CSF levels of LRRK2 were significantly up-regulated in PD patients with the LRRK2 G2019S mutation, compared with controls, sporadic PD and non-manifesting LRRK2 mutation carrier groups [60].